BIOMAT Database Logo BIOMAT Database Logo

Transcutaneous PO2 monitoring in infants with persistent fetal circulation who are receiving tolazoline therapy. 1978

R J Boyle, and W Oh

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010313 Partial Pressure The pressure that would be exerted by one component of a mixture of gases if it were present alone in a container. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Partial Pressures,Pressure, Partial,Pressures, Partial
D006330 Heart Defects, Congenital Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life. Congenital Heart Disease,Heart Abnormalities,Abnormality, Heart,Congenital Heart Defect,Congenital Heart Defects,Defects, Congenital Heart,Heart Defect, Congenital,Heart, Malformation Of,Congenital Heart Diseases,Defect, Congenital Heart,Disease, Congenital Heart,Heart Abnormality,Heart Disease, Congenital,Malformation Of Heart,Malformation Of Hearts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014043 Tolazoline A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn. Benzalolin,Divascol,Pridazole,Priscol,Priscoline,Tolazoline Hydrochloride,Tolazoline Monohydrochloride

Related Publications

R J Boyle, and W Oh
Transcutaneous PO2 monitoring of flap circulation following surgery.
January 1979, Birth defects original article series,
R J Boyle, and W Oh
Validity of transcutaneous PO2 monitoring as compared with intra-arterial PO2 monitoring in newborn infants.
May 1982, Lancet (London, England),
R J Boyle, and W Oh
[Tolazoline and dopamine in the management of persistent fetal circulation].
August 1984, Orvosi hetilap,
R J Boyle, and W Oh
Transcutaneous PO2 monitoring.
December 1979, Critical care medicine,
R J Boyle, and W Oh
Reliability of transcutaneous monitoring of arterial PO2 in newborn infants.
March 1974, Archives of disease in childhood,
R J Boyle, and W Oh
[Evaluation of peripheral circulation in infants with aortic coarctation by transcutaneous pO2 measurement].
October 1991, Grudnaia i serdechno-sosudistaia khirurgiia,
R J Boyle, and W Oh
Limitations of transcutaneous PO2 and PCO2 monitoring in infants with bronchopulmonary dysplasia.
August 1984, Pediatrics,
R J Boyle, and W Oh
Transcutaneous pO2 monitoring in anaesthesia.
January 1976, European journal of intensive care medicine,
R J Boyle, and W Oh
Hearing loss in infants with persistent fetal circulation.
May 1988, Pediatrics,
R J Boyle, and W Oh
[Tolazoline and dopamine in the treatment of the persistent fetal circulation syndrome].
October 1983, Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde,
Copied contents to your clipboard!